Open AccessEfficacy and safety of hyperbaric oxygen treatment in SARS-COV-2 (COVID-19) pneumonia: a systematic review
Author(s) -
Sylvain Boet,
Cole Etherington,
George Djaiani,
Andrea C. Tricco,
Lindsey Sikora,
Rita Katznelson
Publication year - 2021
Publication title -
diving and hyperbaric medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.389
H-Index - 20
eISSN - 2209-1491
pISSN - 1833-3516
DOI - 10.28920/dhm51.3.271-281
Subject(s) - medicine , mechanical ventilation , intubation , medline , adverse effect , meta analysis , randomized controlled trial , intensive care medicine , cohort study , pneumonia , covid-19 , cohort , emergency medicine , surgery , disease , political science , infectious disease (medical specialty) , law
The need for intubation and mechanical ventilation among COVID-19 patients is associated with high mortality rates and places a substantial burden on the healthcare system. There is a strong pathophysiological rationale suggesting that hyperbaric oxygen treatment (HBOT), a low-risk and non-invasive treatment, may be beneficial for COVID-19 patients. This systematic review aimed to explore the potential effectiveness and safety of HBOT for treating patients with COVID-19.